Skip to contentB
BioCorRx Inc.
B
BICXBioCorRx Inc. Q1 2020 · 10-Q
Revenue$36.90K$36.90K−43.5% vs Q1 2019 Net Income-$1.08M-$1.08MN/M vs Q1 2019 EPS Diluted-$0.20-$0.20N/M vs Q1 2019 Operating Income-$1,517,666N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCorRx Inc. · CIK 1443863 · Engraved from SEC EDGAR
Margins · derivedOperating margin-4113.5%−1845.5 pt vs Q1 2019
Net margin-2922.3%−209.9 pt vs Q1 2019
ended Mar 31, 2020 · filed May 15, 2020 · 45 d after period end